Spending allocation covers salaries, consultancy, litigation, material expense and regulatory costs.
Bornav Raychaudhury goes on a journey to this beautiful Himalayan town in West Bengal.
It was a riot of colour that designer duo Mayank Anand and Shraddha Nigam showcased on Day Three of the LFW.
What transpires when a novel inspires a fashion show.
The anti-depressant drug market in the US is primarily ruled by Effexor XR (Venlafaxine) of Wyeth (now owned by Pfizer).
Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19 and it is being tested on more than 1,500 coronavirus patients in New York.
Ranbaxy, originally promoted by the Singh family, was acquired by Japan's Daiichi Sankyo late last year.
Year 2008 results of India's largest drug maker, Ranbaxy Laboratories, and Wockhardt were also impacted by forex losses. Companies such as Aurobindo and Orchid are also expected to post forex losses, say analysts.
GlaxoSmithKline Plc's anti-migraine drug brand, Imitrex, is turning out to be a good revenue earner for Indian generic companies.
Make a style statement by wearing the right colour!
Dr Reddy's Laboratories, Jubilant Organosys, Orchid Chemicals, Aurobindo Pharma and Shasun Chemicals and Drugs are among those who have borrowed either to expand locally or to acquire companies abroad, but are now struggling to repay the dues, analysts say. Some of the companies' debt now exceeds their market capitalisation, as local and global investors sold stocks on concerns over slowdown and falling revenues. A few drug makers may be forced to sell assets to repay debt.
And the celebrations continue!
Pharma majors are collaborating with foreign companies to develop newer drugs.
Teva Pharmaceutical Industries Ltd has sued Indian drug makers, including Ranbaxy Laboratories and Dr Reddy's, for alleged patent violation of ingredients used in Coreg, used for treatment of cardiovascular diseases.
United States-based drug major Forest Laboratories has sued three Indian pharmaceutical companies -- Orchid Chemicals and Pharmaceuticals, Lupin and Wockhardt -- along with four other manufacturers for coming up with imitations of patented drugs in the US.
Prominent luxury hotel groups like JW Mariott, Royal Orchid, Taj and Intercontinental are using the Indian Premier League (IPL) cricket tournament to offer promotional food and beverage (F&B) packages to lure more customers in a sluggish economy.
It is a Budget with a strong emphasis on agriculture, education, healthcare and infrastructure.
The renovations at the old hotels will be complete in two and a half years and tariffs will range between Rs 2,500 and Rs 4,000
The 34-year-old Gujarat cueist beat countryman Ashok Shandilya by six frames to four in the final.
The increasing number of generic players tapping the US market for known molecules has resulted in pricing pressures and lean margins.
After cuisine, it's foreign flowers which have hit the desi market in a big way. Carnation cuttings, bright Gerberas, Poinsettias, Alstroemeria and orchids, the demand for all these is gorwing in the Indian market, according to industry experts.
Over the past one year, since the helpline became functional (on September 8, 2006), a total of 3,110 grievances have been registered.
Though letter of allotments of land were issued to a few hotel chains like Royal Orchid and Signet Hotels for 20 sites last year, land could not be transferred due to the objections raised by the Rail Land Development Authority. The hotel plan was unfolded by the IRCTC in 2006 and accordingly 100 railway sites were selected for setting up budget hotels on public private partnership model.
Post a correction 14,000 cannot be ruled out post March 2007 results.
The defending champion beat countryman Dhruv Sitwala in the final.
The employee stock options, which lost its charm following the dot-com bust of late 90s and crashing markets, are regaining popularity with more and more companies using them to attract and retain talent, say industry insiders.
Domestic pharma giant Ranbaxy Laboratories Limited has topped the list of patent filers in the area of drug applications from the Third World countries last year with 64 new formulations.\n\n\n\n
The woman in question is a young Mumbai-based cake designer.
A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.
About 600 screaming fans were held back by a line of policemen outside the team's central Bangkok hotel.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances